Is rectal administration of a glycerin or bisacodyl suppository appropriate in a vomiting child, and how should the fever be managed when there is no leukocytosis?

Rectal Suppositories in Vomiting Children

Yes, rectal administration of glycerin or bisacodyl suppositories is appropriate and specifically indicated when a child is vomiting, as this bypasses the oral route and ensures medication delivery. 1

Suppository Use in Vomiting Children

The 2017 Italian Pediatric Society Guidelines explicitly state that antipyretics should be administered orally as the primary route, but rectal administration is appropriate in the setting of vomiting 1. This represents a clear exception to the general preference for oral medications.

Practical Considerations for Suppository Selection:

For constipation management:

• Bisacodyl suppository (10 mg) works within 30-60 minutes, significantly faster than the 6-12 hour onset of oral tablets 2
• FDA labeling approves bisacodyl suppositories for children 6-12 years at half the adult dose (5 mg), and full dose (10 mg) for children ≥12 years 3
• Glycerin suppositories are particularly effective in children and may trigger high-amplitude propagating contractions even when bisacodyl fails 4

Important caveat: While suppositories are widely used in some countries (27% of French parents used them for fever management 5), they should be reserved for situations where oral administration is truly not feasible. The Italian guidelines specifically discourage routine rectal administration outside of vomiting scenarios 1.

Fever Management Without Leukocytosis

Fever without elevated white blood cell count does not exclude serious bacterial infection in children and requires risk stratification based on age, clinical appearance, and specific clinical criteria.

Age-Based Approach:

Neonates and young infants (≤90 days):

• This age group is at highest risk for invasive bacterial infection despite normal WBC counts 6
• Infants <28 days have the highest risk and require the most aggressive evaluation 6
• Fever is often the only sign of serious illness in young infants, making laboratory values alone insufficient for risk assessment 6
• Rectal temperature measurement is most accurate and mandatory in this age group 6

Older children:

• Approximately 75% of well-appearing febrile children without an identified source will have self-limited viral infections 6
• Clinical appearance and specific examination findings matter more than isolated WBC values
• Normal WBC does not rule out bacterial infection—clinical judgment remains paramount

Key Management Principles:

Antipyretic administration:

• Use antipyretics to control the child's discomfort, not simply to reduce temperature 1
• Oral route preferred; rectal route appropriate if vomiting present 1
• Do not use antipyretics preemptively to prevent febrile seizures or reduce vaccine-related fever 1
• Avoid combined paracetamol and ibuprofen due to unfavorable risk-benefit ratio 1

Common pitfall: The absence of leukocytosis can provide false reassurance. In neonates and young infants especially, serious bacterial infections including bacteremia and meningitis can present with fever alone and normal initial laboratory values 6. The prevalence of invasive bacterial infection in young febrile infants is 1-2%, which represents significant risk requiring thorough evaluation 6.

Critical decision point: If the child is <90 days old with fever, regardless of WBC count, a comprehensive evaluation for serious bacterial infection is warranted given the increased morbidity and mortality associated with delayed diagnosis 6.